![](/img/cover-not-exists.png)
CAVEAT: A comparison of cerivastatin 0.4 mg and 0.8 mg with atorvastatin 10 mg and 20 mg in patients with combined (type IIB) dyslipidaemia
Ma, P., Hegele, R., Yale, J.F., Schwartz, B.Volume:
2
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/s1567-5688(01)80058-1
Date:
May, 2001
File:
PDF, 173 KB
english, 2001